Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress (Q35103873)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress |
scientific article |
Statements
1 reference
Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress (English)
1 reference
Liqun Huang
1 reference
Chi C Wong
1 reference
Gerardo G Mackenzie
1 reference
Yu Sun
1 reference
Ka Wing Cheng
1 reference
Kvetoslava Vrankova
1 reference
Ninche Alston
1 reference
Nengtai Ouyang
1 reference
Basil Rigas
1 reference
28 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference